F&C Asset Management’s ResMed RMD Stock Holding History

F&C Asset Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	$2.57M	Buy	57,441 +14,099	+33%	+$633K	0.03%	404
2013 Q4	$2.04M	Buy	43,342 +20,013	+86%	+$1.01M	0.02%	439
2013 Q3	$1.23M	Buy	23,329 +6,647	+40%	+$322K	0.02%	513
2013 Q2	$753K	Buy	+16,682	New	+$792K	0.01%	599

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

F&C Asset Management's RMD Position: Q1 2014 in Review

F&C Asset Management increased its ResMed (RMD) stake by 33% in Q1 2014, buying an estimated $633K and bringing the position to 57,441 shares worth $2.57M. The position accounts for 0.03% of the portfolio, ranked #404.

F&C Asset Management first reported a position in RMD in Q2 2013 and has held it in 4 quarters since. 318 funds tracked by Wall St. Rank hold RMD as of Q1 2014.

F&C Asset Management held 57,441 shares of ResMed worth $2.57M as of Q1 2014.
F&C Asset Management bought 14,099 ResMed shares in Q1 2014, an estimated $633K.
ResMed made up 0.03% of F&C Asset Management's portfolio in Q1 2014, its #404 holding.
F&C Asset Management first reported a position in ResMed in Q2 2013 and has held it in 4 quarters since.
318 funds tracked by Wall St. Rank held ResMed as of Q1 2014.

Based on F&C Asset Management's 13F filing for Q1 2014, filed 14 May 2014.